Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I Demand!!!

The company is required to report earnings in a transparent fashion. That is about it.

A logical assumption is that PTSC Q is accurate. This would suggest 17 licenses plus the J2.5 settlement is 10mil.

Not bad for a small company. However, the longterm concern is that the avg cost of a license of 500 or 600K is not going to get PTSC to the next level.

It will take an acquisition to do that. To date nothing suggests this company is going in this direction.

It's concerning as far as I'm concerned.

Share
New Message
Please login to post a reply